| Date Filed | Type | Description |
| 10/25/2010 |
15-12B
| Form 15-12B - Securities registration termination [Section 12(b)] |
| 10/20/2010 |
EFFECT
| Form EFFECT - |
| 10/18/2010 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 10/15/2010 |
SC 13D/A
| SOON SHIONG PATRICK reports a 0% stake in ABRAXIS BIOSCIENCE, INC. |
| 10/15/2010 |
8-K
| Quarterly results |
| 10/15/2010 |
25-NSE
| Form 25-NSE - |
| 10/12/2010 |
425
| Form 425 - Prospectuses and communications, business combinations |
| 10/05/2010 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 10/04/2010 |
425
| Form 425 - Prospectuses and communications, business combinations |
| 09/14/2010 |
DEFM14A
| Form DEFM14A - Definitive proxy statement relating to merger or acquisition |
| 09/10/2010 |
PRER14A
| Form PRER14A - Preliminary Proxy Soliciting materials |
| 08/05/2010 |
10-Q
| Quarterly Report for the period ended June 30, 2010 |
| 08/04/2010 |
425
| Form 425 - Prospectuses and communications, business combinations |
| 07/30/2010 |
425
| Form 425 - Prospectuses and communications, business combinations |
| 07/30/2010 |
425
| Form 425 - Prospectuses and communications, business combinations |
| 07/29/2010 |
PREM14A
| Form PREM14A - Preliminary proxy statements relating to merger or acquisition |
| 07/29/2010 |
BW
| Abraxis BioScience and Specialised Therapeutics Announce Approval to Market ABRAXANE for Metastatic Breast Cancer in New Zealand |
| 07/23/2010 |
BW
| ABRAXANE® Approved for Marketing in Japan for Breast Cancer |
| 07/19/2010 |
BW
| Bull & Lifshitz, LLP Announces Investigation of the Acquisition of Abraxis BioScience Inc. |
| 07/12/2010 |
BW
| Faruqi & Faruqi, LLP Investigates Potential Breaches of Fiduciary Duties by the Board of Abraxis BioSciences, Inc. - ABII |
| 07/08/2010 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership |
| 07/08/2010 |
425
| Form 425 - Prospectuses and communications, business combinations |
| 07/07/2010 |
BW
| The Law Office of Joseph Klein Investigates Possible Breach of Fiduciary Duty by the Board of Abraxis BioSciences Inc. - ABII |
| 07/02/2010 |
SC 13D/A
| SOON SHIONG PATRICK reports a 82.1% stake in ABRAXIS BIOSCIENCE, INC. |
| 07/02/2010 |
BW
| Wolf Haldenstein Investigates Abraxis Bioscience, Inc. Proposed Acquisition |
| 07/01/2010 |
425
| Form 425 - Prospectuses and communications, business combinations |
| 07/01/2010 |
8-K
| Form 8-K - Current report |
| 07/01/2010 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| 07/01/2010 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| 06/30/2010 |
BW
| Law Offices of Howard G. Smith Announces Investigation On Behalf of Shareholders of Abraxis BioScience, Inc. |
| 06/30/2010 |
BW
| Robbins Umeda LLP Announces an Investigation of the Acquisition of Abraxis BioScience Inc. by Celgene Corporation |
| 06/30/2010 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| 06/30/2010 |
8-K
| Other Events, Financial Statements and Exhibits |
| 06/30/2010 |
425
| Form 425 - Prospectuses and communications, business combinations |
|